Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display

3872 - Association of IFNγ production and NK cytotoxicity in PBL of breast cancer patients


10 Oct 2016


Poster display


Sandra Radenkovic


Annals of Oncology (2016) 27 (6): 1-14. 10.1093/annonc/mdw362


S.S. Radenkovic1, V. Jurisic2, R. Dzodic3, G. Konjevic4

Author affiliations

  • 1 Department Of Radiation Oncology And Diagnostics, Institute of Oncology and Radiology of Serbia, 11000 - Belgrade/RS
  • 2 Department Of Pathophysiology, School of Medicine University of Kraguje, Kragujevac/RS
  • 3 Department Of Surgical Oncology, Institute of Oncology and Radiology of Serbia, Belgrade/RS
  • 4 Department Of Experimental Research, Institute of Oncology and Radiology of Serbia, Belgrade/RS


Abstract 3872


New insights revealed a critical role for endogenously produced IFNɣ in promoting host responses to tumors. In this sense, molecular mechanisms underlying immune dysfunction that include the role of IFNɣ in immune responses are not clearly defined in breast cancer.


PBL of breast cancer patients and healthy controls were analyzed for IFNɣ expression and NK cell activity using flow cytometry and 51Cr-release assay, respectively.


Patients in early clinical stage of breast cancer had significantly decreased NK cell cytotoxicity compared to controls. However, patients with advanced clinical stage had significantly decreased NK cell cytotoxicity compared to early breast cancer patients and controls. Positive correlation was shown between intracellular level of IFNɣ in PBL and NK cell activity in both healthy controls and all investigated patients. However, in patients with advanced disease stages positive correlation between intracellular IFNɣ level in PBL and NK cell activity was found, while there was no correlation between the IFNɣ level in PBL and NK cell activity in patients in early disease stage. IL-2 increased NK cell cytotoxicity in breast cancer patients and control. Furthermore, IFNα showed this effect also in patients and controls.


In this study we show that, in breast cancer patients, lower IFNɣ level and reduced NK cell cytotoxicity, important in the control of tumor growth, are associated with tumor progression. These results indicate that IFNɣ level and NK cell cytotoxicity may represent possible targets in designing new therapeutic agents in this disease.

Clinical trial identification

Legal entity responsible for the study

National Projects funded by Ministry of Science Government of Serbia


Ministry of Science


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings